Cargando…

Ovalbumin-Induced Epithelial Activation Directs Monocyte-Derived Dendritic Cells to Instruct Type 2 Inflammation in T Cells Which Is Differentially Modulated by 2′-Fucosyllactose and 3-Fucosyllactose

Allergic sensitization starts with epithelial cell activation driving dendritic cells (DCs) to instruct T helper 2 (Th2) cell polarization. Food allergens trigger intestinal epithelial cell (IEC) activation. Human milk oligosaccharides may temper the allergic phenotype by shaping mucosal immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuurveld, Marit, Kiliaan, Pien C.J., van Grinsven, Sophie E.L., Folkerts, Gert, Garssen, Johan, van't Land, Belinda, Willemsen, Linette E.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643896/ https://www.ncbi.nlm.nih.gov/pubmed/36215948 http://dx.doi.org/10.1159/000526528

Ejemplares similares

An advanced in vitro human mucosal immune model to predict food sensitizing allergenicity risk: A proof of concept using ovalbumin as model allergen
por: Zuurveld, Marit, et al.
Publicado: (2023)

Exposure of Intestinal Epithelial Cells to 2′-Fucosyllactose and CpG Enhances Galectin Release and Instructs Dendritic Cells to Drive Th1 and Regulatory-Type Immune Development
por: Ayechu-Muruzabal, Veronica, et al.
Publicado: (2020)

Human Milk Oligosaccharide 2′-Fucosyllactose Modulates Local Viral Immune Defense by Supporting the Regulatory Functions of Intestinal Epithelial and Immune Cells
por: Ayechu-Muruzabal, Veronica, et al.
Publicado: (2022)

Specific Human Milk Oligosaccharides Differentially Promote Th1 and Regulatory Responses in a CpG-Activated Epithelial/Immune Cell Coculture
por: Zuurveld, Marit, et al.
Publicado: (2023)

Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model
por: Xiao, Ling, et al.
Publicado: (2018)

Immunomodulatory and Prebiotic Effects of 2′-Fucosyllactose in Suckling Rats
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2019)

Epithelial-derived galectin-9 containing exosomes contribute to the immunomodulatory effects promoted by 2’-fucosyllactose and short-chain galacto- and long-chain fructo-oligosaccharides
por: Ayechu-Muruzabal, Veronica, et al.
Publicado: (2022)

Immunomodulation by Human Milk Oligosaccharides: The Potential Role in Prevention of Allergic Diseases
por: Zuurveld, Marit, et al.
Publicado: (2020)

The Combination of 2′-Fucosyllactose with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides that Enhance Influenza Vaccine Responses Is Associated with Mucosal Immune Regulation in Mice
por: Xiao, Ling, et al.
Publicado: (2019)

Multi‐level metabolic engineering of Escherichia coli for high‐titer biosynthesis of 2′‐fucosyllactose and 3‐fucosyllactose
por: Li, Mengli, et al.
Publicado: (2022)

Effect of Rotavirus Infection and 2′-Fucosyllactose Administration on Rat Intestinal Gene Expression
por: Sáez-Fuertes, Laura, et al.
Publicado: (2023)

Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697
por: Zabel, Bryan E., et al.
Publicado: (2020)

Quantifying the human milk oligosaccharides 2’‐fucosyllactose and 3‐fucosyllactose in different food applications by high‐performance liquid chromatography with refractive index detection
por: Christensen, Anne Støvlbæk, et al.
Publicado: (2020)

Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula
por: Austin, Sean, et al.
Publicado: (2018)

Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice
por: Grabinger, Thomas, et al.
Publicado: (2019)

Engineered Bacillus subtilis for the de novo production of 2′-fucosyllactose
por: Zhang, Quanwei, et al.
Publicado: (2022)

Efficient production of 2′-fucosyllactose in unconventional yeast Yarrowia lipolytica
por: Zhang, Yan, et al.
Publicado: (2023)

Human Milk Oligosaccharide 2′-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin
por: Mukherjee, Reshmi, et al.
Publicado: (2022)

Influence of 2′-fucosyllactose and galacto-oligosaccharides on the growth and adhesion of Streptococcus mutans
por: Salli, K., et al.
Publicado: (2020)

Fucoidan But Not 2′-Fucosyllactose Inhibits Human Norovirus Replication in Zebrafish Larvae
por: Tan, Malcolm Turk Hsern, et al.
Publicado: (2021)

Effects of Bifidobacterium with the Ability of 2′-Fucosyllactose Utilization on Intestinal Microecology of Mice
por: Mao, Bingyong, et al.
Publicado: (2022)

2-Fucosyllactose Metabolism by Bifidobacteria Promotes Lactobacilli Growth in Co-Culture
por: Nogacka, Alicja M., et al.
Publicado: (2023)

Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2019)

Oligofructose alone and in combination with 2′fucosyllactose induces physiologically relevant changes in γ-aminobutyric acid and organic acid production compared to sole 2′fucosyllactose supplementation: an in vitro study
por: Jackson, Peter Philip James, et al.
Publicado: (2023)

2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome
por: Kim, Yeon-Ji, et al.
Publicado: (2023)

2′-Fucosyllactose Increases the Abundance of Blautia in the Presence of Extracellular Fucosidase-Possessing Bacteria
por: Horigome, Ayako, et al.
Publicado: (2022)

Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense
por: Bunesova, Vera, et al.
Publicado: (2016)

Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis
por: Sakanaka, Mikiyasu, et al.
Publicado: (2019)

Trophic Interactions of Infant Bifidobacteria and Eubacterium hallii during L-Fucose and Fucosyllactose Degradation
por: Schwab, Clarissa, et al.
Publicado: (2017)

A Fermented Milk Matrix Containing Postbiotics Supports Th1- and Th17-Type Immunity In Vitro and Modulates the Influenza-Specific Vaccination Response In Vivo in Association with Altered Serum Galectin Ratios
por: Ayechu-Muruzabal, Veronica, et al.
Publicado: (2021)

Author Correction: Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2020)

Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2(′)-fucosyllactose
por: Baumgärtner, Florian, et al.
Publicado: (2013)

Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae
por: Yu, Sora, et al.
Publicado: (2018)

Metabolic Fate and Distribution of 2´‐Fucosyllactose: Direct Influence on Gut Microbial Activity but not on Brain
por: Kuntz, Sabine, et al.
Publicado: (2019)

Development of fluorescent Escherichia coli for a whole-cell sensor of 2ʹ-fucosyllactose
por: Shin, Jonghyeok, et al.
Publicado: (2020)

Human Milk Oligosaccharide 2′-Fucosyllactose Induces Neuroprotection from Intracerebral Hemorrhage Stroke
por: Hung, Tsai-Wei, et al.
Publicado: (2021)

Screening of Bifidobacteria with Probiotic Potential from Healthy Infant Feces by Using 2′-Fucosyllactose
por: Zhang, Gongsheng, et al.
Publicado: (2023)

The oligosaccharides 6’-sialyllactose, 2’-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation
por: Perdijk, Olaf, et al.
Publicado: (2018)

Infant Fecal Fermentations with Galacto-Oligosaccharides and 2′-Fucosyllactose Show Differential Bifidobacterium longum Stimulation at Subspecies Level
por: Lindner, Cordula, et al.
Publicado: (2023)

Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
por: Lee, Won-Heong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4nf2409v2kmeorrql4vrh0g9jr